Article
Expanding the genetic burden of low-evidence genes in pulmonary arterial hypertension.
European journal of human genetics : EJHG - 1 Jun 2026
Miranda-Alcaraz Lucía, Mora-Gómez Mónica, Gallego-Zazo Natalia, Cruz-Utrilla Alejandro, Del Cerro Marín María Jesús, Ochoa Parra Nuria, Martín de Miguel Irene, Gutiérrez Ortiz Eva, Jiménez-Estrada Juan Andrés, Parra Alejandro, Cazalla Mario, Ramos Sergio, Rodríguez-Canó Manuel, Silván Cristina, Vásquez-Amell Valeria, Arias Pedro, Nevado Julián, de Jesús Pérez Vinicio, Lapunzina Pablo, Escribano-Subías Pilar, Tenorio-Castano Jair
Abstract excerpt
Pulmonary arterial hypertension (PAH) is a severe disease characterized by elevated pulmonary artery pressure, leading to heart failure and premature death if untreated. Genetic factors significantly contribute to PAH, and several genes have been linked to its development. According to the ClinGen PH-GCEP group, 12 genes have definitive evidence of association with PAH, three have moderate evidence, six have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
